公募基金“限购潮”升温，中欧基金两只明星产品宣布限购

Group 1 - The public fund market is experiencing a trend of subscription limits, with several funds announcing restrictions to manage inflows and protect existing investors' interests [1][3] - On August 9, China Europe Fund announced subscription limits for two of its prominent funds, with a cap of 1 million yuan for the China Europe Sci-Tech Innovation Fund and 100,000 yuan for the China Europe Medical Innovation Fund, effective from August 11 [2] - Since July, approximately 50 actively managed equity funds have issued subscription limit announcements, indicating a broader trend in the industry to control fund sizes during periods of high market enthusiasm [3] Group 2 - Fund managers are implementing subscription limits as a strategy to maintain investment discipline and focus on long-term returns, while also mitigating liquidity risks [1][4] - The China Europe Medical Innovation Fund, managed by renowned fund manager Ge Lan, achieved a one-year return of 85.03%, ranking in the top 2% among similar products, prompting the need for subscription limits [2] - Other funds, such as the China Europe Digital Economy Mixed Fund and Yongying Fund, have also announced subscription limits, reflecting a common practice among high-performing funds during market peaks [4]